JP2020535225A5 - - Google Patents

Download PDF

Info

Publication number
JP2020535225A5
JP2020535225A5 JP2020538758A JP2020538758A JP2020535225A5 JP 2020535225 A5 JP2020535225 A5 JP 2020535225A5 JP 2020538758 A JP2020538758 A JP 2020538758A JP 2020538758 A JP2020538758 A JP 2020538758A JP 2020535225 A5 JP2020535225 A5 JP 2020535225A5
Authority
JP
Japan
Prior art keywords
agent according
cholestasis
ceradelpal
day
pruritus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020538758A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020535225A (ja
JP7023371B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/052490 external-priority patent/WO2019067373A1/en
Publication of JP2020535225A publication Critical patent/JP2020535225A/ja
Publication of JP2020535225A5 publication Critical patent/JP2020535225A5/ja
Application granted granted Critical
Publication of JP7023371B2 publication Critical patent/JP7023371B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020538758A 2017-09-26 2018-09-24 胆汁うっ滞性そう痒の処置 Active JP7023371B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762563395P 2017-09-26 2017-09-26
US62/563,395 2017-09-26
PCT/US2018/052490 WO2019067373A1 (en) 2017-09-26 2018-09-24 TREATMENT OF CHOLESTATIC PRURIT

Publications (3)

Publication Number Publication Date
JP2020535225A JP2020535225A (ja) 2020-12-03
JP2020535225A5 true JP2020535225A5 (enExample) 2021-11-04
JP7023371B2 JP7023371B2 (ja) 2022-02-21

Family

ID=64564950

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020538758A Active JP7023371B2 (ja) 2017-09-26 2018-09-24 胆汁うっ滞性そう痒の処置

Country Status (26)

Country Link
US (2) US20190105291A1 (enExample)
EP (3) EP3687523B1 (enExample)
JP (1) JP7023371B2 (enExample)
KR (1) KR102376794B1 (enExample)
CN (1) CN111132675B (enExample)
AU (2) AU2018342323B2 (enExample)
BR (1) BR112020005074A2 (enExample)
CA (1) CA3076614C (enExample)
CY (1) CY1124894T1 (enExample)
DK (1) DK3973959T3 (enExample)
ES (2) ES3012120T3 (enExample)
FI (1) FI3973959T3 (enExample)
HR (2) HRP20250022T1 (enExample)
HU (2) HUE070033T2 (enExample)
IL (2) IL273569B (enExample)
LT (2) LT3973959T (enExample)
MX (1) MX392537B (enExample)
PL (2) PL3973959T3 (enExample)
PT (2) PT3687523T (enExample)
RS (1) RS62790B1 (enExample)
SG (1) SG11202002253SA (enExample)
SI (2) SI3687523T1 (enExample)
SM (1) SMT202200171T1 (enExample)
UA (1) UA125600C2 (enExample)
WO (1) WO2019067373A1 (enExample)
ZA (1) ZA202001646B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10272058B2 (en) 2014-03-20 2019-04-30 Cymabay Therapeutics, Inc. Treatment of intrahepatic cholestatic diseases
ES2701094T3 (es) 2014-03-20 2019-02-20 Cymabay Therapeutics Inc Tratamiento de enfermedades colestáticas intrahepáticas
US12053445B2 (en) 2016-03-31 2024-08-06 Genfit Methods of treatment of cholestatic diseases
US10512622B2 (en) 2017-07-14 2019-12-24 Cymabay Therapeutics, Inc. Treatment of intrahepatic cholestatic diseases
KR20210078515A (ko) 2018-10-18 2021-06-28 아비어, 인크. 만성 신장 질환-연관 소양증의 치료 방법 및 장치
KR20220140762A (ko) * 2020-02-10 2022-10-18 장피트 엘라피브라노에 의한 원발 담즙성 담관염의 치료
CN115884765A (zh) 2020-08-26 2023-03-31 基恩菲特公司 用于治疗原发性胆汁性胆管炎的组合物和方法
CN116490191A (zh) * 2020-10-20 2023-07-25 葛兰素史克知识产权第二有限公司 治疗胆汁淤积性瘙痒的方法
RS65546B1 (sr) 2021-02-01 2024-06-28 Cymabay Therapeutics Inc Tretman holangiopatija sa seladelparom
US20240252499A1 (en) 2023-01-29 2024-08-01 Cymabay Therapeutics, Inc. Treatment of uremic pruritus
KR20250139304A (ko) * 2023-01-29 2025-09-23 사이머베이 쎄라퓨틱스, 인코퍼레이티드 만성 소양증 피부병의 치료
WO2025250635A1 (en) * 2024-05-28 2025-12-04 Avior, Inc. Use of nalmefene hydrochloride buccal films in treating liver disease associated pruritus
WO2026030533A1 (en) 2024-07-31 2026-02-05 Cymabay Therapeutics, Inc. Seladelpar for use in treating liver disease
US20260207538A1 (en) 2024-12-20 2026-07-23 Gilead Sciences, Inc. Combinations for liver disease
CN121023009A (zh) * 2025-10-31 2025-11-28 浙江大学医学院附属妇产科医院(浙江省妇女医院、浙江省妇女保健院) 基于唾液样本的妊娠期肝内胆汁淤积症易感基因多重pcr—ngs筛查方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA87467C2 (xx) 2003-09-19 2009-07-27 Янссен Фармацевтика Н.В 4-((феноксіалкіл)тіо)феноксіоцтова кислота та її аналоги$4-((феноксиалкил)тио)феноксиуксусная кислота и ее аналоги
JO3006B1 (ar) 2005-09-14 2016-09-05 Janssen Pharmaceutica Nv املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك
ES2701094T3 (es) * 2014-03-20 2019-02-20 Cymabay Therapeutics Inc Tratamiento de enfermedades colestáticas intrahepáticas
JP2020533339A (ja) * 2017-09-13 2020-11-19 ノバルティス アーゲー Fxrアゴニストを含む組合せ

Similar Documents

Publication Publication Date Title
FI3973959T3 (fi) Kolestaattisen kutinan hoito seladelpaarilla
JP2017508817A5 (enExample)
JP2018518537A5 (enExample)
JP2019518022A5 (enExample)
JP2022058688A5 (enExample)
JP2018193377A5 (enExample)
JP2014511374A5 (enExample)
RU2018146504A (ru) Лечение внутрипеченочных холестатических заболеваний
RU2018133158A (ru) Способы применения агонистов fxr
JP2019524865A5 (enExample)
JP2018035160A5 (enExample)
JP2018529779A5 (enExample)
JP2010077141A5 (enExample)
JP2017503820A5 (enExample)
JP2018162255A5 (enExample)
JP2021528488A5 (enExample)
JP2008512426A5 (enExample)
JP2018172440A5 (enExample)
JP2015523546A5 (enExample)
JP2018529742A5 (enExample)
JP2009538898A5 (enExample)
JP2016511753A5 (enExample)
JP2010502736A5 (enExample)
JP2020111586A5 (enExample)
JP2016502981A5 (enExample)